|
||||||||||||
|
antiplatelets drug in cardiovascular prevention - Clinical trials resultsSystematic review and meta-analysis of clinical trials about antiplatelets drug in cardiovascular prevention. Clinical trials enrolled the following type of patients :
See also:
Other antiplatelets drug: Aspirin , aspirin + dypiridamol , aspirine , cangrelor , cangrelor up front , Clopidogrel , clopidogrel + aspirin , clopidogrel+aspirin , cloricromene , Dipyridamol+Aspirin , dypiridamol , enoxaparin , indobufen , ketanserine , kétensérine , picotamide , prasugrel , Prasugrel and Bivalirudin , roxifiban , sulfinpyrazone , suloctidil , sulotroban , ticlopidine , various , Entry term : Primary Prevention, Secondary prevention, cardiometabolic syndrom, abciximab , acetylsalicylic acid lysinate , ajoene , aloxistatin , Alprostadil , anagrelide , andrographolide , argatroban , Aspirin , bepafant , beraprost , canadine , carboprostacyclin , cilostamide , cilostazol , clentiazem , clopidogrel , daltroban , dauricine , dazmegrel , defibrotide , Dipyridamole , Disintegrins , draflazine , echistatin , efegatran , enfenamic acid , Epoprostenol , eptifibatide , essential 303 forte , fibrinopeptides gamma , glycocalicin , helenalin , ibudilast , ifetroban , Iloprost , indobufen , jararhagin , Ketanserin , KW 3635 , lamifiban , magnolol , mexidol , Milrinone , naftopidil , nitroaspirin , oxophenylarsine , Pentoxifylline , picotamide , piroximone , plafibride , policosanol , protopine , pycnogenols , Quin2 , ramatroban , relcovaptan , resveratrol , rhodostomin , ridogrel , rosmarinic acid , S-nitrosocysteine , S-Nitrosoglutathione , S-nitrosomercaptoethanol , S-Nitrosothiols , sarpogrelate , Satigrel , sevoflurane , sibrafiban , sulotroban , tautomycin , thromboxane A2, carbocyclic , Ticlopidine , tirofiban , tranilast , Trapidil , trequinsin , triflavin , triflusal , trilinolein , vapiprost , xemilofiban , |
|||||||||||
|
||||||||||||